Mindmed to host earnings call to discuss second quarter 2022 financial results and provide business update

New york , aug. 4, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on thursday, august 11, 2022, at 4:30 p.m. edt to discuss its financial results for the quarter ended june 30, 2022 and provide a business update.
MNMD Ratings Summary
MNMD Quant Ranking